| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000009449 |
| Receipt No. | R000011080 |
| Official scientific title of the study | Effect of epoetin beta pegol treatment on renal anemia and blood pressure control in non-dialytic CKD patients |
| Date of disclosure of the study information | 2013/01/01 |
| Last modified on | 2018/09/05 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Effect of epoetin beta pegol treatment on renal anemia and blood pressure control in non-dialytic CKD patients
|
|
| Title of the study (Brief title) | Effect of epoetin beta pegol on renal anemia and blood pressure in non-dialytic CKD patients
|
|
| Region |
|
|
| Condition | ||
| Condition | non-dyalitic chronic kidney disease (CKD) | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To verify effect of epoetin beta pegol injection on blood Hb level and mean blood pressure as well as its fluctuation during outpatient clinic in non-dialytic patients. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Blood Hb level before and after epoetin beta pegol treatment and mean blood pressure as well as its fluctuation during outpatient clinic. |
| Key secondary outcomes | Correlation between blood pressure fluctuation and incidence of cardiovascular events before and after epoetin beta pegol treatment. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Epoetin beta pegol injection to treat renal anemia | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Chronic kidney disease stage 4 and 5, non-dialytic
2. Hb level lower than 11g/dl 3. Longer than 6 months of therapeutic period estimated until initiation of dialysis 4. Volantary consent obtained after adequate explanation on the study |
|||
| Key exclusion criteria | 1. Allergic to erythropoiesis stimulating agents (ESA)
2. Either malignant diseases, severe infectious diseases, or significant adverse conditions complicated 3. Other inadequate occasions assessed by the attending physician |
|||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Kenichiro Asano |
| Organization | Kurashiki Central Hospital |
| Division name | Nephrology |
| Address | 1-1-1 Miwa Kurashiki-city Okayama 710-8602 Japan |
| TEL | 086-422-0210 |
| Public contact | |
| Name of contact person | Kenichiro Asano |
| Organization | Kurashiki Central Hospital |
| Division name | Nephrology |
| Address | 1-1-1 Miwa Kurashiki-city Okayama 710-8602 Japan |
| TEL | 086-422-0210 |
| Homepage URL | http://kchsps1/SiteDirectory/d3750/SitePages/Home.aspx |
| ka11734@kchnet.or.jp | |
| Sponsor | |
| Institute | Kurashiki Central Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kurashiki Central Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 倉敷中央病院 Kurashiki Central Hospital |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011080 |